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Available online 24 February 2017The Northwestern region of Ethiopia is affected by both tsetse and non-tsetse transmitted
trypanosomosis with a signiﬁcant impact on livestock productivity. The control of
trypanosomosis in Ethiopia relies on either curative or prophylactic treatment of animals
with diminazene aceturate (DA) or isometamidium chloride (ISM). In the present work; ques-
tionnaire survey, cross-sectional and experimental studies were carried out to; a) assess the
utilization of trypanocidal drugs; b) determine the prevalence of bovine trypanosomosis and;
c) assess the drug resistant problems respectively in Tsetse and non-tsetse infested areas on
NW Ethiopia. A total of 100 respondents were included for the survey and the questionnaires
focused on the drug utilization practices for the control of Trypanosomosis. Blood from cattle
640 (324 cattle tested in 2011, 316 cattle tested in 2012) and 795 (390 cattle tested in
2011, 405 cattle tested in 2012) were examined from tsetse infested and non-tsetse infested
areas respectively using the buffy coat technique and thin blood smear for the detection of try-
panosomes and measurement of packed cell volume (PCV). For the assessment of trypanocidal
drug resistance three isolates, one from tsetse (TT) and two from non-tsetse (NT) areas were
used on thirty six trypanosome naïve calves. The experimental animals were divided randomly
into six groups of six animals (TT-ETBS2-DA, TT-ETBS2-ISM, NT-ETBD2-DA, NT-ETBD2-ISM, NT-
ETBD3-DA and NT-ETBD3-ISM), which were infected with T. vivax isolated from a tsetse-
infested or non-tsetse infested area with 2 × 106 trypanosomes from donor animals, and in
each case treated with higher dose of DA or ISM. The results of the questionnaire survey
showed trypanosomosis was a signiﬁcant animal health constraint for 84% and 100% of the
farmers questioned in non-tsetse and tsetse infested areas of Northwest Ethiopia respectively.
Responses on trypanocidal drug utilization practices indicated that risk factors for the develop-
ment of drug resistance are common and treatment failures are frequently seen. Accordingly,
the majority of farmers in tsetse infested area get trypanocides from drug stores and unautho-
rized sources whereas those from non-tsetse area get from veterinary clinics. Moreover, treat-
ment administration is mainly by animal health personnel and treatment frequency is a
maximum of three times/year/animal in non-tsetse area whereas it is administered mainly
by the farmers more than seven times/year/animal in tsetse infested area. The prevalence ofKeywords:
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41S. Dagnachew et al. / Parasite Epidemiology and Control 2 (2017) 40–49trypanosomosis varied from 17.59% in 2011 to 25.0% in 2012 in tsetse infested areas with a sig-
niﬁcant (P = 0.023) difference. Similarly, in non-tsetse infested area the prevalence was varied
from 3.85% in 2011 to 5.93% in 2012 without signiﬁcant rise. Trypanosoma congolense (75%)
was the most prevalent followed by T. vivax (20.58%) and mixed infections (4.41%) in tsetse
infested area while in non-tsetse infested area only T. vivax was detected. The overall mean
PCV in parasitaemic animals (20 ± 2.3 SD) was signiﬁcantly (P b 0.001) lower than that of
aparasitaemic animals (27 ± 4.3 SD). The assessment of trypanocidal drug resistance tests re-
vealed one isolate of non-tsetse infested area against DA in group NT-ETBD2-DA is resistant to
the higher dose used with 3 relapsing animals (50% relapses) in the group. Another two re-
lapses were detected one against ISM for the isolate from tsetse infested area (TT-ETBS2-
ISM) and one against DA for another isolate (NT-ETBD3-DA) from the non-tsetse area. In con-
clusion, trypanosomosis is widely prevalent in both study areas causing signiﬁcant reduction in
the mean PCV values. Farmers' trypanocidal utilization practices appear to pose risks of drug
resistance problems. The in vivo drug resistance tests indicated the presence of resistant para-
sites with the higher dose against DA for NT-ETBD2 isolate and suspected resistance problems
were detected against ISM and DA for TT-ETBS2 and NT-ETBD3 isolates respectively. Therefore,
trypanosomosis is a major constraint in Northwest Ethiopia and drug resistance is a threat in
the control of trypanosomosis in both study areas.
© 2017 Published by Elsevier Ltd on behalf of World Federation of Parasitologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
In Ethiopia, trypanosomosis is a serious constraint to livestock production and agricultural development. Due to the advance-
ment of tsetse ﬂies into formerly free areas, an estimated 220,000 km2 areas is presently affected by tsetse ﬂies (Abebe, 2005).
The most prevalent trypanosome species are T. congolense and T. vivax. Various authors reported that the prevalence of
trypanosomosis in tsetse infested areas range from 11.85–37% (Rowlands et al., 1993; Abebe and Jobre, 1996; Dagnachew et
al., 2005; Degu et al., 2012; Fikru et al., 2014). In non-tsetse infested areas of Northwest Ethiopia, the prevalence of
trypanosomosis was in the range of 2–9% (Eneyew and Abebe, 1997; Cherenet et al., 2006; Sinshaw et al., 2006).
Trypanosomosis is controlled either by vector control or parasite control, or a combination of both. Parasite control currently
relies on a small group of trypanocidal compounds, and new compounds are unlikely to become available in the near future
(Barrett et al., 2004). Consequently, the use of these drugs must be carefully monitored and trypanosome populations need to
be screened regularly for the appearance of drug-resistant parasites. There is increasing evidence that the efﬁcacy of chemother-
apy is becoming reduced by the widespread development of trypanosome drug resistance (Van den Bossche et al., 2000;
Delespaux et al., 2008). Recent reports (Sow et al., 2012; Vitouley et al., 2012) conﬁrmed ISM and DA resistance in T. vivax and
T. congolense in West Africa. In Ethiopia the appearance of drug-resistant trypanosomes has been reported by several authors
(Mulugeta et al., 1997; Afework et al., 2000; Tewelde et al., 2004; Shimelis et al., 2008a; Moti et al., 2012; Dagnachew et al.,
2014). However, the reports on drug resistance are focused mainly on T. congolense. Therefore, this study was conducted with
the aim of assessing risk factors for the development of trypanocidal drug resistance, determine the prevalence of bovine
trypanosomosis and to test the efﬁcacy of DA and ISM at higher doses against T. vivax from tsetse and non-tsetse infested
areas of Northwest Ethiopia.
2. Materials and methods
The questionnaire survey and prevalence were undertaken in two districts; from a tsetse infested district (Jabitehenan) and a
non - tsetse infested district (Bahar Dar Zuria) in Northwest Ethiopia (Fig. 1). Jabitehenan is located between 10° 30′ 42″ N and
37° 7′ 11″ E with altitude range from 1100 to 1500 m above sea level (m.a.s.l.) whereas Bahir Dar Zuria is located 11° 36′ 0″ N
and 37° 22′ 60″ E with altitude range from 1800 to 2000 m.a.s.l. The climate alternates with long summer rain fall (June–Septem-
ber) and a winter dry season (October–May) with mean annual rain fall of 1569.4 mm and the mean temperature varies between
16.7 °C - 31.6 °C. The livestock population includes cattle, sheep, goat and equines which are an integral part of the livelihood of
the people. Cattle are particularly important in the agricultural activities where the farmers are dependent on oxen power for crop
production (Central Statistical Agency (CSA), 2013). The assessment of trypanocidal drug resistance tests was conducted at Debre
Zeit in the premises of College of Veterinary Medicine and Agriculture of Addis Ababa University.
2.1. Study methodology
2.1.1. Questionnaire survey
A questionnaire survey was conducted to gather data on the problems of trypanosomes and practice of trypanocidal drugs
usage in the study areas. The main component of the questionnaire focused during the interview includes; types of trypanocidal
drug used, sources of drugs, treatment frequency and personnel's involved in the treatment practice of trypanosome cases etc. To
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mat. The interviewed people were selected randomly from the study areas.2.1.2. Cross-sectional study
Cross-sectional studies were conducted in the months of October 2011 and 2012 to determine the prevalence of bovine
trypanosomosis as well as measurement of packed cell volume (PCV) values between parasitaemic and aparasitaemic animals.2.1.3. Study animals
The study animals included indigenous Zebu cattle populations found in the two study districts. The husbandry system de-
pends on natural grazing and crop residues and kept in a traditional communal management system. Animals obtain water in
the rainy season from seasonal rivers while in the dry season from perennial rivers ﬂowing long in their locality.2.1.4. Sampling method and sample size determination
A stratiﬁed multistage random sampling method was applied according to Thrusﬁeld, (2007). Two districts were selected from
Amhara National Regional State (ﬁrst stage) to represent tsetse infested and non-tsetse infested areas of Northwest Ethiopia
(Fig. 1). The lists of Peasant Association's 5PA's members within districts were compiled from data obtained in the district's agri-
cultural ofﬁce (second stage). Herds selected within the same grazing land were considered as strata and representative number
of animals were sampled. Parameters like sex, age, sampling period and areas were recorded for each individual animal during
sample collection. Age was categorized into two (b2 years and N2 years) groups. The sample size was determined based on
the expected prevalence rate of 20% and 10% in tsetse infested and non-tsetse infested areas respectively, with an absolute desired
precision of 5% at conﬁdence level of 95%. Therefore, a total of 1435 cattle of which 640 (324 in 2011 and 316 in 2012) from
tsetse infested area and 795 (390 in 2011 and 405 in 2012) from non-tsetse infested area were examined in the months of
October.Fig. 1. Map of administrative regions of Ethiopia and administrative zones of regions showing the study areas: tsetse infested area (Jabitehenan district of West
Gojjam zone: 1) and non-tsetse infested area (Bahir Dar Zuria district of West Gojjam zone: 2). Tsetse infected areas of Ethiopia is encircled in red. (Source: Mod-
iﬁed from World Food Program Vulnerability Analysis and Mapping Unit, Ethiopia, July 1998).
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Paired blood sampleswere collected from auricular vein of each animal using two hematocrit capillary tubes thatwere ﬁlled 3/4 of
the height and sealed with Cristaseal. The capillary tubes were centrifuged at 12000 rpm for 5 min ﬁrst to measure the PCV. There-
after, the capillary was cut 1 mm below the buffy coat to include the top layer of red blood cells, and the content of the capillary
tube was expressed onto a clean slide, mixed and covered with a 22 × 22mm coverslip (Paris et al., 1982). Then the slide was exam-
ined for trypanosomes based on their movement in the microscopic ﬁeld. Conﬁrmation of trypanosome species by morphological
characteristics was done after staining with Giemsa by examination with oil immersion microscopy (Murray and Mcintyre, 1977).
2.1.6. Isolation of Trypanosoma vivax parasites
Isolation of T. vivax parasites were carried out during 2012 study period for the assessment of experimental trypanocidal drug
resistance tests. The isolates were collected from mono-infected animals with T. vivax using a parasitological technique (Paris et
al., 1982) in the ﬁeld. Stabilates were prepared from these animals at peak parasitaemia based on “rapid matching method”
(Herbert, 1976). These stabilates were passaged into donor calves to see the typical motility and morphological structure of T.
vivax using the parasitological technique and tested with PCR (Masiga et al., 1992) to conﬁrm pure T. vivax.
2.1.7. Assessment of trypanocidal drug resistance
2.1.7.1. Experimental study site. The experimental study was carried out from March–June 2014 in a ﬂy-proof animal facility in the
premises of the College of Veterinary Medicine and Agriculture of Addis Ababa University at Debre Zeit, Ethiopia located at 9°6′N
and 37°15′E with an altitude of 1920 m.a.s.l. about 47 km east of Addis Ababa.
2.1.7.2. Experimental animals. A total of 36 indigenous Zebu (Bos indicus) cattle aged 9 to 12 months were purchased from a try-
panosome free area. The animals were transferred into a ﬂy-proof experimental animal house. Animals were ear-tagged, exam-
ined for the presence of trypanosomes and other blood parasites using blood smear technique and fecal egg count method
(Paris et al., 1982; Soulsby, 1982) for helminthes. To avoid occurrence of pneumonia associated with transport stress and change
of environment, each animal was treated on arrival with oxytetracycline 20% w/v (Chongqing Fangtong Animal Pharmaceutical
Co., Ltd., China). All animals were treated with albendazole 2500 mg and Ivermectin at 0.2 mg/kg body weight (Chengdu
Qiankum Veterinary Pharmaceuticals Co. Ltd., China) to control internal and external parasites. After treatment prior to the begin-
ning of the experiment animals were acclimatized for one month for the new environment, handling and feeding conditions.
2.1.7.3. Experimental design. The efﬁcacy of higher doses of diminazene aceturate (DA) and isometamidium chloride (ISM) were
tested against T. vivax isolates in experimentally infected cattle based on previous established protocols (Eisler et al., 2001). An-
imals were assigned randomly into six groups of six animals each: group TT-ETBS2-DA = infected with T. vivax isolate 2 from
tsetse infested area and treated with DA, group TT-ETBS 2-ISM = infected with T. vivax isolate 2 from tsetse infested area and
treated with ISM, group NT-ETBD2-DA = infected with T. vivax isolate 2 from non-tsetse infested area and treated with DA,
group NT-ETBD2-ISM = infected with T. vivax isolate 2 from non-tsetse area and treated with ISM and group NT-ETBD3-
DA = infected with T. vivax isolate 3 from non-tsetse infested area and treated with DA and group NT-ETBD3-ISM = infected
with T. vivax isolate 3 from non-tsetse infested area and treated with ISM.
2.1.7.4. Trypanosome challenge. Each experimental animal received 2 mL of infected blood from the donor animals at 106 trypano-
somes/mL via the intravenous route.
2.1.7.5. Trypanocidal drugs. The trypanocidal drugs tested were diminazene aceturate (BERENIL R.T.U, Lot No.A189A01, Exp.03-
2015, 20 Spartan Rd., Spartan, Republic of South Africa) and isometamidium chloride (Veridium T.M, Lot No.198A1, Exp. 06-
2015, CEVA SANTE ANIMALE, Libourne-France) were tested. Diminazene aceturate was injected as a 7% solution at dose of
7 mg/kg body weight and isometamidium chloride was injected as 1% solution at dose of 1 mg/kg of body weight. Sterile distilled
water was used to dissolve appropriate quantities of the drugs before it was administered to the animals. The drugs were admin-
istered through intramuscular route to animals on the basis of accurate body weight measurement taken immediately before
treatment using digital weighing machine (TAL-TEC Livestock Scale, South Africa). All the trypanocidal drugs used for the exper-
iment were tested for their quality (active ingredient) and fulﬁll certiﬁcate of the standards.
2.1.7.6. Feeding and animalmanagement.Animals were fed grass hay and supplemented with concentrates of wheat bran and green
Elephant grass. Water and mineral lick were freely available. The handling of animals during the experiment was based on inter-
national guiding principles for biomedical research involving animals, as proposed by the Council for International Organizations
of Medical Sciences (CIOMS), (1985). The research was authorized by the Animal Research Ethics Review Committee of the Col-
lege of Veterinary Medicine and Agriculture of the Addis Ababa University (Permit No: VM/ERC/003/04/013).
2.1.7.7. Trypanocidal drug resistance tests. After all experimentally infected animals of a group became parasitaemic they were treat-
ed with the higher doses DA or ISM. Starting from the treatment date, cattle were monitored for parasitaemia by the buffy coat
technique twice a week for 100 days. When relapse (detection of trypanosomes after drug treatment) was detected the animal
was treated with a second different drug.
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Data was recorded during sample collection, parasitological examination and PCV measurement as well as questionnaire re-
sponses into Excel Spread Sheets to create a database and imported to SPSS version 20 for analysis. Descriptive statistics, Student's
t-test and Logistic regression were used to explain results and compare variables. Logistic regression on the prevalence of trypano-
somes was performed on the variables; sampling years, sampling areas, sex and age groups. Student's t-test was employed to
compare the mean PCV of the parasitaemic animals with that of the aparasitaemic animals. For the drug resistance tests the in-
terpretation was as follows; if relapse not was detected within 100 days after the ﬁrst and the second trypanocidal drug admin-
istration, the treatment was considered successful and the trypanosomes sensitive to drug treatment. Relapse infections detected
within 100 days of administration of a trypanocidal drug were taken as indicative of resistance. If relapse occurred in N20% of the
cattle tested, the strain was considered resistant to the dose of drug used (Eisler et al., 2001).
2.3. Results
2.3.1. Questionnaire survey
All the respondents in tsetse infested and non-tsetse infested areas rear cattle primarily for draught purpose and income gen-
eration. Trypanosomosis was ranked as the ﬁrst animal health constraint and known for the last two decades by 100% and 84% of
the respondents from tsetse infested and non-tsetse infested areas respectively. Control of trypanosomosis in both areas relies
mainly on treatment of animals with trypanocidal drugs; isometamidium chloride (ISM) and diminazene aceturate (DA). The
vast majority of respondents (90%) from non-tsetse infested areas get trypanocidal drugs from veterinary clinics and drug
shops whereas most respondents (82%) in tsetse infested areas ascertained that their drug sources were drug stores and unautho-
rized shops (Fig. 2A). On the other hand, most farmers in non-tsetse infested area send their cattle to veterinary clinics or animalFig. 2. Questionnaire response on trypanocidal drug utilization practices in the study areas. (A) Sources of trypanocidal drugs for treatment, (B) administration of
trypanocidal drugs in cattle, (C) trypanocidal drug treatment frequencies/animal/year.
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selves or family members (Fig. 2B). According to the respondents, 40%, 20% and 40% of them use DA, ISM and both respectively
in non-tsetse infested areas as compared to 2%, 30% and 68% in tsetse infested areas. However, the drug of their choice was DA in
non-tsetse infested areas (52%) and ISM in the tsetse infested areas (94%). Eighty percent of respondents in tsetse infested areas
treat their animals more than seven times/per year/animal whereas 80% of those in non-tsetse infested area give a maximum of
three injections per year/animal (Fig. 2C). Trypanocidal treatment failures were reported by 66% and 94% of the respondents in
non-tsetse and tsetse infested areas respectively.
2.3.2. Parasitological ﬁndings
Out of the total 640 and 795 animals examined using parasitological techniques respectively from tsetse-infested and non-
tsetse-infested areas, 21.25% and 4.91% (P b 0.001, 95%CI: 2.367–11.517) were found positive for the disease. In tsetse infested
areas, the prevalence was signiﬁcantly higher in 2012 compared to the ﬁnding in 2011 but no signiﬁcant variation was observed
in non-tsetse infested area (Table 1). Among the trypanosome species identiﬁed signiﬁcantly higher prevalence was detected for
T. congolense compared to T. vivax and mixed infections. Generally, the prevalence was signiﬁcantly higher in male than female
animals and in adults than young animals while such difference was not signiﬁcant in the non-tsetse infested areas. When T.
vivax was considered alone, the prevalence between tsetse infested (4.38%) and non-tsetse infested (4.91%) areas was not signif-
icantly different.
2.3.3. Isolation of T. vivax parasites
Isolation of T. vivax parasites were carried out in October 2012, consequently, 3 T. vivax isolates one from tsetse infested area
and 2 from non-tsetse infested area were collected in stabilates forms. The stabilates were passaged into donor calves and develop
infections and showed the typical motility and morphological structure of T. vivax using parasitological technique (Paris et al.,
1982), and conﬁrmed as pure T. vivax with PCR (Masiga et al., 1992). These stabilates were named as TT-ETBS2 for tsetse infested
area and NT-ETBD2 and NT-ETBD3 for the non-tsetse infested area were used for the experimental drug resistance tests. The ab-
breviations indicated in the name of isolates stand as follows (TT - tsetse infested area, NT - non-tsetse infested area, ET - Ethiopia,
BS - Birsheleko area of Jabitehenan district, BD-Bahir Dar Zuria district) i.e. T. vivax isolated from Ethiopia at Birsheleko areas of
Jabitehenan district for tsetse infested area and at Bahir Dar Zuria district for non-tsetse infested area and the numbers are the
sequential order of the isolates.
2.3.4. Hematological ﬁndings
The hematological ﬁndings of the examined animals were investigated by comparing the PCV values with respect to trypano-
some infection, species of trypanosomes, sampling sites and years. Consequently, overall mean PCV was signiﬁcantly reduced in
parasitaemic animals compared to aparasitaemic animals (P b 0.001) when samples were pooled from both study sites and
study years. Similarly, irrespective of trypanosome status, mean PCV was signiﬁcantly lower (P b 0.001) in tsetse infested area
compared to non-tsetse infested area. However, the mean PCV values were not signiﬁcantly different between sampling years
(Table 2). The decrease in mean PCV was similar when data were sorted according to parasite species that the animal was har-
boring which was also true for those in non-tsetse areas compared to values for apparently aparasitaemic animals.
2.3.5. Parasitemia and PCV values in experimental drug resistance tests
Clinical forms of trypanosomosis were observed until treatment was applied in all groups of experimentally infected animals.
Establishment of infection was ﬁrst detected within four days of challenge in animals infected with the non-tsetse isolate while on
day seven for tsetse isolate infected groups. All infected animals became parasitaemic and treatment was given on day fourteenTable 1
Prevalence of bovine trypanosomosis in tsetse infested and non-tsetse infested areas of Northwest Ethiopia in October 2011 and 2012.
Parameters Group % Positive in 2011 % Positive in 2012 95%CI b/n years
Parasite detection Positive (tve) TT 17.59 (N = 324)a 25.0 (N = 316)b 0.437 0.939
Positive (tve) NT 3.85 (N = 390)c 5.93 (N = 405)c 0.328 1.228
Parasite species Tc TT 13.27 (N = 324)a 18.67 (N = 316)b 0.421 0.995
Tv TT 3.70 (N = 324)c 5.06 (N = 316)c 0.309 1.436
M TT 0.62 (N = 324)c 1.27 (N = 316)c 0.081 2.445
Tv NT 3.85 (N = 390)c 5.93 (N = 405)c 0.328 1.228
Sex Male tve TT 10.80 (N = 173)a 19.30 (N = 193)b 1.339 3.042
Female tve TT 6.79 (N = 151)a 15.69 (N = 123)b
Male tve NT 2.11 (N = 194)c 2.96 (N = 196)c 0.577 2.091
Female tve NT 1.79 (N = 196)c 2.96 (N = 209)c
Age Young tve TT 1.85 (N = 80)a 7.28 (N = 113)b 1.077 2.674
Adult tve TT 15.74 (N = 244)c 17.72 (N = 203)c
Young tve NT 1.28 (N = 133)a 0.74 (N = 93)a 0.710 3.470
Adult tve NT 2.56 (N = 257)a 5.19 (N = 312)a
Tc-Trypanosoma congolense, Tv-Trypanosoma vivax, M-mixed (Tc and Tv), TT-tsetse infested area, NT-non-tsetse infested area, tve-positive. In each parameter of
variables, superscripts with different letters indicate signiﬁcant differences between values at P b 0.05.
Table 2
Mean PCV of animals examined for trypanosomosis in both tsetse and non-tsetse infested areas of Northwest Ethiopia.
Parameters Group Number examined Mean PCV SD P-value
Parasite detection Positive 175 20 4.1 0.00
Negative 1260 27 4.3
Sampling years 2011 714 26 4.7 0.05
2012 721 26 4.9
Sampling areas Tsetse area 640 25 5.4 0.00
Non-tsetse area 795 27 4.2
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pared to the isolates from tsetse infested area.
In all cases there was a signiﬁcant reduction in the mean PCV values following infection with compared with before infection
(P ˂ 0.05). Treatment of infected groups has resulted in signiﬁcant improvements in the PCV compared to the values at the day of
treatment (P b 0.05). However, the improvements were not signiﬁcant particularly in relapse detected groups (Fig. 3). The com-
parison of mean PCV improvement between groups showed that animals in group NT-ETNBD2-DA and group NT-ETBD3-DA were
found to show the least PCV improvement (P b 0.001).
2.3.6. Drug resistance test
Prior to treatment, peak parasitaemia was detected in all infected cattle. When the cattle were treated with DA or ISM, the
parasitaemia was signiﬁcantly reduced after 24 h. However, the assessment of drug resistance tests revealed the occurrence of
resistant strains in cattle treated with the higher doses of both drugs. A total of ﬁve animals showed relapses; three from
group NT-ETBD 2-DA) on 21 and 28 dpt, one animal from group NT-ETBD 3-DA) on 35 dpt and another one from group TT-
ETBS 2-ISM) on 49 dpt. From the experiment, it was possible to conclude that T. vivax isolate (NT-ETBD2-DA) from non-tsetse
infested area was found to be resistant at 7 mg/kg body weight of DA. The detection of two relapses one from another non-tsetse
infested isolate for DA at 7 mg/kg body weight and one from tsetse infested isolate for ISM at 1 mg/kg body weight is indicative
of the presence of resistant strains if more isolates were tested and improved diagnostic tests was used. The mean wave of
parasitaemia in all 6 animals prior to treatment is shown, with the mean of the relapsing 1–3 cattle shown post treatment
(Fig. 4).
2.4. Discussion
Bovine trypanosomosis and its impact is well known by the farmers in the study areas although the frequency of respondents
was lower in non-tsetse area than in tsetse area. Similar observations have already been reported by Afework et al., (2000) from
Metekel district of Northwest Ethiopia, Tewelde et al., (2004) from Western Ethiopia and Dagnachew et al., (2005) from North-
west Ethiopia where the cyclical vector tsetse ﬂy are present. Similarly Zewdu et al., (2013) at Baro-Akobo and Gojeb river basins
of Western Ethiopia reported that 94.1% of the respondents considered bovine trypanosomosis accounts for 64.6% of the total an-
nual deaths of cattle in 2011/2012. To combat the problem, farmers reported to use diminazene aceturate (DA) and
isometamidium chloride (ISM), the most commonly available trypanocidal drugs in the areas which are also similar for other
places (Zewdu et al., 2013). The majority of the respondents from non-tsetse infested areas preferred to use DA whereas those
in tsetse infested areas preferred ISM. A similar preference in non-tsetse infested areas has been reported by Van den Bossche
et al., (2000) in the eastern province of Zambia. This could be linked to the fast treatment responses as in case of DA or longevity
of protection from subsequent infections as in the case of ISM when given at a prophylactic dose.Fig. 3. Mean ± SE PCV values before and after treatment either by DA or ISM in young Zebu cattle - six animals per group experimentally infected with
Trypanosoma vivax isolates from tsetse (TT) and non-tsetse infested (NT) areas of Northwest Ethiopia, TT-ETBS2-DA and TT-ETBS2-ISM, NT-ETBD2-DA and NT-
ETBD2-ISM, NT-ETBD3-DA and NT-ETBD3-ISM.
Fig. 4. Mean parasitaemia in young Zebu cattle - six animals per group experimentally infected with T. vivax isolates from tsetse infested (TT-ETBS1 or TT-ETBS2)
and non-tsetse infested (NT-ETBD1or ETBD2 or ETBD3) areas followed by treatment either by DA or ISM. It shows the mean of parasitaemia in all 6 animals prior
to treatment, but the mean of only the relapsing 1–3 cattle days post treatment (dpt). From a total of six cattle in each group of NT-ETBD2-DA and NT-ETBD3-DA
three and one animals showed relapse at 21 and 28 dpt respectively and from a total six cattle in TT-ETBS2-ISM group one animal showed relapse on 49 dpt.
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infested areas as compared to those in non-tsetse areas. This ﬁnding is in agreement with various reports done in Ethiopia
(Afework et al., 2000; Tewelde et al., 2004; Shimelis et al., 2008b; Zewdu et al., 2013). Uilenberg (Uilenberg, 1998) reported
that the number of treatments over a year reﬂects the magnitude of trypanosome challenge in an area. Moreover, most farmers
in the tsetse area and signiﬁcant number of them in non-tsetse area obtain trypanocidal drugs from drug stores and unauthorized
sources without prescription. Altogether, farmers' practices suggest the occurrence of risk factors for emergence of trypanocidal
drug resistance. Reasons for the misuse of trypanocidal drugs could be related to the inadequacies of veterinary services, the avail-
ability of trypanocidal drugs in informal markets and treatment failures that would force them to have the drugs at their back
yard.
In the present study the prevalence of bovine trypanosomosis was 21.25% in tsetse infested areas and 4.91% was in non-tsetse
infested areas which corroborate the report of Jemal and Hugh-Johns (Jemal and Hugh-Johns, n.d.) who reported trypanosomosis
is a major constraint to the utilization of large land resources and also affect livestock, particularly cattle which have a major role
in the agricultural economy of Ethiopia. Similar ﬁndings were also reported by different researchers (Afework et al., 2000;
Tewelde et al., 2004; Dagnachew et al., 2005; Cherenet et al., 2006; Shimelis et al., 2008b). The higher prevalence of
trypanosomosis in tsetse infested area compared to the non-tsetse area might be attributed to the dominance of T. congolense
over T. vivax. Similar ﬁndings were reported in tsetse infested areas of Ethiopia, the dominant trypanosome species was T.
congolense (Rowlands et al., 1995; Leak, 1999; Dagnachew et al., 2005). However, when animals infected with T. vivax alone
were considered, prevalence was low and similar between tsetse infested and non-tsetse infested areas. This might be associated
to T. vivax in these areas establish a more chronic infection and the conventional parasitological techniques might fail to detect the
presence of the parasite in the blood. The lower prevalence reported for T. vivax is in agreement with various workers who report-
ed a prevalence range of 2% to 9% (Eneyew and Abebe, 1997; Cherenet et al., 2006; Sinshaw et al., 2006).
Trypanosome infections were more prevalent in males and adult cattle than in females and young ones. This agrees with the
following ﬁndings (Trail et al., 1994; Magona et al., 2008; Daya and Abebe, 2008; Dayo et al., 2010). The higher prevalence in male
animals might be associated to the frequent exposure of male animals to the bites of vectors during traction period. The age dif-
ference could be linked to reproduction and work stresses to which most adult cattle are exposed for the bite of tsetse ﬂies.
The fact that animal trypanosomosis causes signiﬁcant anemia (Murray and Dexter, 1988; Dagnachew et al., 2005; Cherenet et
al., 2006; Sinshaw et al., 2006; Degu et al., 2012) is supported by the present study. The fall in mean PCV was regardless of the
trypanosome species detected in those parasitological positive animals. Moreover, very comparable lower PCV values were no-
ticed in those animals infected with T. vivax from both study sites; altogether suggesting the pathologic signiﬁcance of T. vivax
in both tsetse and non-tsetse infested areas of Northwest Ethiopia.
The application of trypanocidal drugs is widely practiced to control trypanosomosis in domestic livestock since several decades
either as curative or prophylactic drugs. This long time use of few trypanocides often predisposes the drugs to development of
resistance. As indicated in the questionnaire survey, farmers' practices suggest widespread prevalence of risk factors for emer-
gence of trypanocidal drug resistance. This has prompted us to undertake a controlled experimental trial to investigate the pres-
ence of trypanocidal resistance for T. vivax originated from both tsetse infested and non-tsetse infested areas of Northwest
Ethiopia.
2.4.1. Drug resistance tests
An earlier onset of parasitemia was detected in the NT infected cattle compared to the TT infected cattle. Furthermore, faster
relapses of infection were also detected in the non-tsetse T. vivax origin. Anemia associated with trypanosome infections is mul-
tifactorial and the relative contribution of each mechanism will differ according to the host-parasite model, the phase of anemia
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1976) was not observed in the present work. This might be due to the presence of drug resistant trypanosomes below the limits
of our microscopical detection, though emergence of trypanosomes from drug inaccessible sites, nutritional imbalance and/or re-
duced response of the bone marrow due to exhaustion when the infection runs a chronic course cannot be ruled out (Murray and
Dexter, 1988).
The presence of indiscriminate drug utilization practices and subsequent complaints over the efﬁcacy of the available
trypanocidal drugs in the present study areas was supplemented by the presence of resistant strains for both isolates of the
drugs tested. This would indicate a drug resistance status for these two isolates of T. vivax against both DA and ISM, contrary
to the view expressed by Fairclough, (1963), who suggested that it is difﬁcult to induce resistance to ISM even by repeated
low dosages (0.25–0.5 mg/kg body weight). Our previous experimental studies conﬁrmed the occurrence of resistant strains of
T. vivax against DA and ISM at 3.5 mg/kg and 0.5 mg/kg body weight respectively (Dagnachew et al., 2014). Based on this T.
vivax isolates (TT-ETBS2, NT-ETBD2 and NT-ETBD3) from the two areas were tested using 7 mg/kg DA and 1 mg/kg ISM. Conse-
quently, isolate NT-ETBD2 from non-tsetse infested area was found to be resistant to DA (three out of six animals relapsed).
Codjia et al., (1993) reported resistance to the maximum recommended doses of DA (7 mg/kg body weight) for T. congolense iso-
lates from cattle in the Ghibe valley Western Ethiopia. Moreover, in the present study the ﬁndings of two relapses, one from NT-
ETBD3-DA group from non-tsetse infested area and one from TT-ETBS2-ISM group from tsetse infested area suggests the isolates
are suspected for resistance to the two drugs and hence need further investigation. Similar ﬁndings were reported by Sow et al.,
(2012) indicating T. vivax isolated from Burkina Faso and tested at a dose of 1 mg/kg body weight for ISM was found to be resis-
tant. As it has already been indicated in the epidemiological study, risk factors for prevalence of drug resistance are widespread in
the areas from which the parasites were originated. Higher frequency of treatment, under dosage and mishandling especially
when the drugs are administered by farmers and possible occurrence of poor quality drugs on the market could be reasons for
the development of resistance (Vitouley et al., 2012). On the other hand, the difference in the drug resistance proﬁle between dif-
ferent isolates of the parasite could be explained by the possible variation in exposure of the drugs to such risk factors (Holmes et
al., 2004) and parasite variations in exposure to treatment.
In conclusion, the questionnaire survey underlined trypanosomosis is a major animal health constraint in both tsetse and non-
tsetse infested areas of Northwest Ethiopia and trypanocidal drugs available in the area are exposed to risks of drug resistance.
The cross-sectional studies conformed that bovine trypanosomosis is causing signiﬁcant reduction in the mean PCV of
parasitaemic animals in both areas. T. congolense and T. vivax were species of trypanosomes responsible for the occurrence of
trypanosomosis in tsetse infested areas whereas only T. vivax species was identiﬁed in non-tsetse infested areas. Treatment of in-
fected cattle with the recommend doses of trypanocides showed incomplete parasite clearance, consistent with the occurrence of
resistant strains and adding to growing evidence that such resistance may be a problem. Therefore, appropriate control measures
should be taken in both tsetse infested and non-tsetse infested areas of Northwest Ethiopia.
Conﬂict of interest statement
The authors declare that they have no competing interests and have no any ﬁnancial or personal relationships that could in-
appropriately inﬂuence or bias the content of the paper.
Acknowledgment
The author would like to thank Bahir Dar Regional Veterinary Laboratory for the logistic support and technical assistance dur-
ing the ﬁeld work. This work was funded by Ethio-Belgium VLIR project, GALVmed and the thematic research project ‘Animal
Health Improvement’ of Addis Ababa University.
References
Abebe, G., 2005. Trypanosomosis in Ethiopia. Ethiop. J. Biol. Sci. 4 (1), 75–121.
Abebe, G., Jobre, Y., 1996. Trypanosomiasis: a threat to cattle production in Ethiopia. Rѐvue de Mѐdecine Vѐtѐrinarie 147, 897–902.
Afework, Y., Clausen, P.H., Abebe, G., Tilahun, G., Mehlitz, D., 2000. Multiple-drug resistant Trypanosoma congolense populations in village cattle of Metekel district,
Northwest Ethiopia. Acta Trop. 76, 231–238.
Barrett, M.P., Burchmore, R.J., Stich, A., Lazzari, J.O., Frasch, A.C., Cazzulo, J.J., et al., 2004. Future prospects in chemotherapy for trypanosomiasis. In: Maudlin, I., Holmes,
P.H., Miles, M.A. (Eds.), The Trypanosomosis. CABI Publishing, pp. 445–458.
Central Statistical Agency (CSA), 2013. Agricultural sample survey. Report on livestock and livestock characteristics. Statistical Bulletin No 573, Volume II, Addis Ababa,
Ethiopia.
Cherenet, T., Sani, R.A., Speybroeck, N., Panandam, J.M., Nadzr, S., Van den Bossche, P., 2006. A comparative longitudinal study of bovine trypanosomosis in tsetse-free
and tsetse-infested zones of the Amhara Region, Northwest Ethiopia. Vet. Parasitol. 140, 251–258.
Codjia, V., Mulatu, W., Majiwa, P.A.O., Leak, S.G.A., Rowlands, G.J., Authie, E., et al., 1993. Epidemiology of bovine trypanosomosis in the Ghibe Valley Southwest Ethi-
opia: occurrence of populations of Trypanosoma congolense resistant to diminazene, isometamidium and homidium. Acta Trop. 53, 151–163.
Council for International Organizations of Medical Sciences (CIOMS), 1985s. International Guiding Principles for Biomedical Research Involving Animals-Developed.
Dagnachew, S., Sangwan, A.K., Abebe, G., 2005. Epidemiology of bovine trypanosomosis in the Abay (Blue Nile) basin areas of Northwest Ethiopia. Revue et Médecine
Véterinarie 58, 151–157.
Dagnachew, S., Terefe, G., Abebe, G., Barry, D.J., McCulloch, R., Goddeeris, B.M., 2014. In vivo experimental drug resistance study on Trypanosoma vivax isolates from
tsetse infested and non-tsetse infested areas of Northwest Ethiopia. Acta Trop. 146, 95–100.
Daya, T., Abebe, G., 2008. Seasonal dynamics of tsetse and trypanosomosis in selected sites of southern nation, Nationalities and Peoples Regional State, Ethiopia. Ethi-
opian Veterinary Journal 12, 77–92.
49S. Dagnachew et al. / Parasite Epidemiology and Control 2 (2017) 40–49Dayo, G.-K., Bengaly, Z., Messad, S., Bucheton, B., Sidibe, I., Cene, B., et al., 2010. Prevalence and incidence of bovine trypanosomosis in agro-pastoral area of southwest-
ern Burkina Faso. Res. Vet. Sci. 88, 470–477.
Degu, F., Ayalew, B., Tewodros, F., Mersha, C., 2012. Occurrence of bovine trypanosomosis, in the Blue Nile river basin, Northwest Ethiopia. European Journal of Applied
Sciences 4, 129–135.
Delespaux, V., Geysen, D., Van den Bossche, P., Geerts, S., 2008. Molecular tools for the rapid detection of drug resistance in animal trypanosomes. Trends Parasitol. 24,
236–242.
Eisler, M.C., Brandt, J., Bauer, B., Clausen, P.-H., Delespaux, V., Holmes, P.H., et al., 2001. Standardised tests in mice and cattle for the detection of drug resistance in
tsetse-transmitted trypanosomes of African domestic cattle. Vet. Parasitol. 97, 171–182.
Eneyew, M., Abebe, G., 1997. Bovine trypanosomosis in South Gondar administrative zone bordering Lake Tana (Ethiopia) in the apparent absence of Glossina. Journal
of the Ethiopian Veterinary Association 1, 19–34.
Fairclough, R., 1963. A comparison of isometamidium, Samorin, Berenil and Ethidium bromide under field conditions in Kenya. Vet. Rec. 75, 855–858.
Fikru, R., Hagos, A., Roge, S., Reyna-Bello, A., Gonzatti, M.I., Bekana, M., et al., 2014. A proline racemase based PCR for identification of Trypanosoma vivax in cattle blood.
PLoS One 9, e84819.
Herbert, W.J., 1976. Trypanosoma brucei: a rapid “matching” method for estimating the host's parasitaemia. Exp. Parasitol. 40, 427–431.
Holmes, P.H., Jennings, F.W., 1976. In: Soulsby, E.J.L. (Ed.), Pathophysiology of parasitic infection. Academic Press, New York, pp. 199–210.
Holmes, P.H., Eisler, M.C., Geerts, S., 2004. Current chemotherapy of animal trypanosomiasis. In: Maudlin, Ian, Holmes, Peter H., Miles, Michael A. (Eds.), The Trypano-
somiasis. CABI International, Wallingford, UK, pp. 431–444.
A. Jemal, M. E. Hugh-Johns, Association of tsetse control with health and productivity in the Didessa Valley, Western Ethiopia, Prev. Med. 22, 29–40.
Leak, S.G.A., 1999. Tsetse Biology and Ecology: Their Role in the Epidemiology and Control of Trypanosomosis. CABI Publishing, Wallingford, UK.
Magona, J.W., Walubengo, J., Origin, J.T., 2008. Acute hemorrhagic syndrome of bovine trypanosomosis in Uganda. Acta Trop. 107, 186–191.
Masiga, D.K., Smyth, A.J., Hayes, P., Bromidge, T.J., Gibson, W.C., 1992. Sensitive detection of trypanosomes in tsetse flies by DNA amplification. Int. J. Parasitol. 22,
909–918.
Moti, Y., Fikru, R., Van Den Abbeele, J., Büscher, P., Van den Bossche, P., Duchateau, L., et al., 2012. Ghibe river basin in Ethiopia: present situation of trypanocidal drug
resistance in Trypanosoma congolense using tests in mice and PCR-RFLP. Vet. Parasitol. 189, 197–203.
Mulugeta, W., Wilkes, J., Mulatu, W., Majiwa, P.A.O., Masake, R., Peregrine, A.S., 1997. Long-term occurrence of Trypanosoma congolense resistant to diminazene,
Isometamidium and Homidium in cattle at Ghibe, Ethiopia. Acta Trop. 64, 205–217.
Murray, M., Dexter, T.M., 1988. Anemia in bovine African trypanosomiasis: a review. Acta Trop. 45, 389–432.
Murray, M.P.K., Mcintyre, W.I.M., 1977. An improved parasitological technique for the diagnosis of African trypanosomosis. Trans. Soc. Trop. Med. Hyg. 71, 325–326.
Paris, J., Murray, M., McOimba, F., 1982. A comparative evaluation of the parasitological techniques currently available for the diagnosis of African animal
trypanosomosis in cattle. Acta Trop. 39, 307–316.
Rowlands, G.J., Mulatu, W., Authie, E., Leak, S.G.A., Peregrine, A.S., 1993. Epidemiology of bovine trypanosomosis in the Ghibe valley, Southwest Ethiopia. Acta Trop. 53,
135–150.
Rowlands, G.J., Mulatu, W., Nagda, S.M., Dolan, R.B., d'Ieteren, G.D.M., 1995. Genetic variation in packed red cell volume and frequency of parasitaemia in East African
Zebu cattle exposed to drug resistant trypanosomes. Livest. Prod. Sci. 43, 75–84.
Shimelis, D., Arun, K.S., Getachew, A., 2008a. Assessment of trypanocidal drug resistance in cattle of the Abay (Blue Nile) Basin areas of Northwest Ethiopia. Ethiopian
Veterinary Journal 12, 45–59.
Shimelis, D., Arun, K.S., Getachew, A., 2008b. Assessment of trypanocidal drug resistance in cattle of the Abay (Blue Nile) basin areas of Northwest Ethiopia. Ethiopian
Veterinary Journal 12, 45–59.
Sinshaw, A., Abebe, G., Desquesnes, M., Yon, W., 2006. Biting flies and Trypanosoma vivax infection in three highland districts bordering Lake Tana, Ethiopia. Vet.
Parasitol. 142, 35–46.
Soulsby, E.J.L., 1982. Helminths, Arthropods and Protozoa of Domesticated Animals. seventh ed. Tindall, London, pp. 630–645.
Sow, A., Sidibé, I., Bengaly, Z., Marcotty, T., Séré, M., 2012. Field detection of resistance to isometamidium chloride and diminazene aceturate in Trypanosoma vivax from
the region of the Boucledu Mouhoun in Burkina Faso. Vet. Parasitol. 187, 105–111.
Tewelde, N., Abebe, G., Eisler, M.C., McDermott, J., Greiner, M., Afework, Y., et al., 2004. Application of field methods to assess isometamidium resistance of trypano-
somes in cattle in western Ethiopia. Acta Trop. 90, 163–170.
Thrusfield, M., 2007. Sampling. Veterinary Epidemiology, fourth ed. Blackwell Science Ltd., London, UK, pp. 221–254.
Trail, J.C.M., Wissocq, N., d'Ieteren, G.D.M., Kakiese, O., Murray, M., 1994. Patterns of Trypanosoma vivax and T. congolense infection differ in young N'Dama cattle and
their dams. Vet. Parasitol. 55, 175–183.
Uilenberg, G., 1998. A Field Guide for the Diagnosis, Treatment and Prevention of African Animal Trypanosomosis. FAO, Rome, Italy 158 pp.
Van den Bossche, P., Doran, M., Connor, R.J., 2000. An analysis of trypanocidal drug use in the Eastern Province of Zambia. Acta Trop. 75, 247–258.
Vitouley, H.S., Sidibe, I., Bengaly, Z., Marcotty, T., Van Den Abbeele, J., Delespaux, V., 2012. Is trypanocidal drug resistance a threat for livestock health and production in
endemic areas? Food for thoughts from Sahelian goats infected by Trypanosoma vivax in Bobo Dioulasso (Burkina Faso). Vet. Parasitol. 190, 349–354.
Zewdu, S., Getachew, T., Hagos, A., 2013. Farmers' perception of impacts of bovine trypanosomosis and tsetse fly in selected districts in Baro-Akobo and Gojeb river
basins, Southwestern Ethiopia. BMC Vet. Res. 9, 214.
